News

Genoskin kicks off fundraising campaign at CCI FINDays The Genoskin team is now officially ready to launch its biggest fundraising campaign so far, which aims to finance our international expansion. Pascal Descargues, our CEO, is heading for Paris next week to attend the CCI FINDays, the first in a series of fundraising meetings. CCI FINDays is a French event designed to help small and start-upRead more

GENOSKIN TO ATTEND 47TH ANNUAL ESDR MEETING 2017 Here at Genoskin, we're pleased to announce our presence at the 47th Annual Meeting of the European Society for Dermatological Research (ESDR). The meeting will take place in Salzburg, Austria from September 27th to 30th, 2017. The ESDR aims to promote research in dermatology and skin biology and open up the dialogue betweenRead more

HistoSkin® FFPE skin tissue blocks In order to help our customers conduct the skin research they need, Genoskin launches HistoSkin® to simplify access to FFPE human skin tissue blocks and sections for studies and analysis. HistoSkin® offers a wide range of fully characterized FFPE tissue blocks and sections and provides new research opportunities involving human skin. A wide selection of donors Every year, Genoskin collects a wide range

Read more

Genoskin obtains US patent for skin models Genoskin is pleased to announce the approval of a US patent for our “system for the maintenance and survival of skin biopsies in transport and its applications”. The patent describes our method to transform human skin biopsies in ready-to-use and functional ex vivo skin models. The human skin biopsies that are used in our models

Read more

On February 3, 2017, Genoskin was awarded a finalist spot in the third edition of the Start-up Connexion Contest. This event brings together innovative research companies and potential investors to highlight and finance projects with high economic value. The Start-up Connexion Contest is a combined initiative of the CNRS (French National Center for Scientific Research) and the AEF Media Group, which specializes in

Read more

Genoskin obtains ISO9001 certification The entire Genoskin team is proud to announce that we obtained the ISO9001:2015 certification in January 2017. This certificate validates the quality and consistency of our design and R&D services as well as the commercialization of human skin models, cells and tissues to pharmaceutical, chemical and cosmetic industries. Consistent quality for skin models and R&D programs The

Read more